Muscle wasting in cancer: opportunities and challenges for exercise in clinical cancer trials

• Egile Nagusiak: Ciaran M. Fairman (Egilea), Simon Lønbro (Egilea), Thomas D. Cardaci (Egilea), Brandon N. VanderVeen (Egilea), Tormod S. Nilsen (Egilea), Angela E. Murphy (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2022-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Low muscle in cancer is associated with an increase in treatment‐related toxicities and is a predictor of cancer‐related and all‐cause mortality. The mechanisms of cancer‐related muscle loss are multifactorial, including anorexia, hypogonadism, anaemia, inflammation, malnutrition...